These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Multiple forms of rat-serum alpha 1-protease inhibitor. Involvement of sialic acid in the multiplicity of three original forms. Ikehara Y; Miyasato M; Ogata S; Oda K Eur J Biochem; 1981 Apr; 115(2):253-60. PubMed ID: 6786878 [TBL] [Abstract][Full Text] [Related]
84. Periodate-induced transformation of human peripheral blood lymphocytes and the resultant oxidation of membrane sialyl, galactosyl and fucosyl residues. Banchereau JF; Danois DM; Guenounou M; Durand GM; Agneray JC Biochim Biophys Acta; 1981 Nov; 678(1):98-105. PubMed ID: 6272876 [TBL] [Abstract][Full Text] [Related]
85. Application of the selective periodate oxidation of sialic acids. III. Identification of neuraminidase-sensitive and neuraminidase-resistant sialic acids and their side chain O-acyl variants. Reid PE; Arratoon C; Owen DA Histochem J; 1988 Nov; 20(11):645-50. PubMed ID: 3225199 [No Abstract] [Full Text] [Related]
87. Preparation of neuraminidase-resistant human alpha 1-protease inhibitor and its clearance in rat blood circulation. Omichi K; Savic G; Yoshida A Int J Biochem; 1983; 15(11):1345-51. PubMed ID: 6315502 [TBL] [Abstract][Full Text] [Related]